Magnoflorine induces apoptosis and autophagy by inhibiting AKT/mTOR and promoting p38 MAPK signaling pathways, and enhances the sensitivity of breast cancer cells to doxorubicin (DOX) (Wei, Xiaojun & Peilong, 2020). This evidence concerns the gene MTOR and breast carcinoma.